Shareholders really need to visit the company before making those kind of statements in order to better understand the technology. First, most companies don’t manufacture their tests to include all their supporting products. Second, no other company has a product that can test for the amount of allergens utilizing 4-5 blood drops. Third, the technology is smaller, most of the equipment is reusable, and robust machinery perform most of the work. The technology is smaller, but superior, this coupled with their superior microarray slides allows for mass production in less time.
So lets sum things up... The technology is smaller, simpler, capable of mass production, reusable equipment, require less time to process, require less man power, and cost efficient shipping using the blood cards.
ArrayIT manufactures all their tests and supporting products. They also process their tests at their CLIA approved laboratory benchmarked by CAP. The company has aced several proficiency tests.
News 
Market Data 
Discover 
